Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥43.7bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥87.6bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥42.3bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥2.6bn2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥2.3bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥2.6bn2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥4.3bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥2.7bn2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥2.5bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥55.8bnat 2026-06-30Cons.Assets
Total assets¥59.2bnat 2025-12-31Cons.Assets
Total assets¥53.9bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥27.6bnat 2026-06-30Cons.Liabilities
Total liabilities¥32.3bnat 2025-12-31Cons.Liabilities
Net assets / equity¥28.2bnat 2026-06-30Cons.Net assets
Net assets / equity¥27.0bnat 2025-12-31Cons.Net assets
Net assets / equity¥25.5bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥831mat 2026-06-30Cons.Cash and deposits
Cash and deposits¥884mat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥826mat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥879mat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥797mat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥882mat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow¥35m2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥377m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.062026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.722025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.572025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥5m
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥6m
Enzymatic Medicinereportable segmentrevenue2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentrevenue external2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentsegment profit2026-01-01 → 2026-06-30¥936m
Liquorreportable segmentrevenue2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue external2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥6m
Liquorreportable segmentsegment profit2026-01-01 → 2026-06-30¥1.2bn
Real Estatereportable segmentrevenue2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentrevenue external2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentsegment profit2026-01-01 → 2026-06-30¥396m
—segment totalrevenue2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue external2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥6m
—segment totalsegment profit2026-01-01 → 2026-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥49m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥44m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥6m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥17m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥17m
Enzymatic Medicinereportable segmentrevenue2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentrevenue external2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentsegment profit2025-01-01 → 2025-06-30¥568m
Liquorreportable segmentrevenue2025-01-01 → 2025-06-30¥39.1bn
Liquorreportable segmentrevenue external2025-01-01 → 2025-06-30¥39.0bn
Liquorreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥12m
Liquorreportable segmentsegment profit2025-01-01 → 2025-06-30¥1.4bn
Real Estatereportable segmentrevenue2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentrevenue external2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentsegment profit2025-01-01 → 2025-06-30¥389m
—segment totalrevenue2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥12m
—segment totalsegment profit2025-01-01 → 2025-06-30¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 577
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)EY新日本有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)石  田  大  輔
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)青  木     一
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1InterimDuration42268000000JPY
Net sales (5-year summary)InterimDuration43673000000JPY
Net sales (5-year summary)Prior1YearDuration87630000000JPY
Ordinary income loss (5-year summary)Prior1InterimDuration2398000000JPY
Ordinary income loss (5-year summary)InterimDuration2650000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration4291000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1InterimDuration1855000000JPY
Profit loss attributable to owners of parent (5-year summary)InterimDuration1970000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration3102000000JPY
Comprehensive income (5-year summary)Prior1InterimDuration1841000000JPY
Comprehensive income (5-year summary)InterimDuration2209000000JPY
Comprehensive income (5-year summary)Prior1YearDuration3507000000JPY
Net assets (5-year summary)Prior1InterimInstant25456000000JPY
Net assets (5-year summary)InterimInstant28240000000JPY
Net assets (5-year summary)Prior1YearInstant26976000000JPY
Total assets (5-year summary)Prior1InterimInstant53904000000JPY
Total assets (5-year summary)InterimInstant55815000000JPY
Total assets (5-year summary)Prior1YearInstant59235000000JPY
Basic earnings loss per share (5-year summary)Prior1InterimDuration32.57
Basic earnings loss per share (5-year summary)InterimDuration35.06
Basic earnings loss per share (5-year summary)Prior1YearDuration54.72
Diluted earnings per share (5-year summary)Prior1InterimDuration-
Diluted earnings per share (5-year summary)InterimDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1InterimInstant0.457
Equity to asset ratio (5-year summary)InterimInstant0.492
Equity to asset ratio (5-year summary)Prior1YearInstant0.442
Net cash provided by used in operating activities (5-year summary)Prior1InterimDuration-377000000JPY
Net cash provided by used in operating activities (5-year summary)InterimDuration35000000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration3568000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1InterimDuration-1241000000JPY
Net cash provided by used in investing activities (5-year summary)InterimDuration-1109000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-1927000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1InterimDuration1534000000JPY
Net cash provided by used in financing activities (5-year summary)InterimDuration1021000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-1644000000JPY
Cash and cash equivalents (5-year summary)Prior1InterimInstant797000000JPY
Cash and cash equivalents (5-year summary)InterimInstant826000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant879000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember65586196
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember65586196
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant65586196
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant65586196
Number of shares heldInterimInstant_No1MajorShareholdersMember13267000
Shareholding ratioInterimInstant_No1MajorShareholdersMember0.2381

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass